HOME >> BIOLOGY >> NEWS
JCI table of contents November 1, 2004

Mutations in Transporter Protein Effect HDL Levels in the General Population

High cholesterol levels are a major contributor to heart disease in particular atherosclerosis. High density lipoprotein (HDL) has an essential role in reducing cholesterol levels, and therefore has a cardioprotective effect. There is therefore a great deal of research into the genetic underpinnings that control HDL blood levels. Individuals with Tangier disease have essentially no HDL in the blood. Recently the mutation underlying this disorder was identified in the ABC transporter A1 (ABCA1) gene, which is essential for the first step in the synthesis of HDL. When both ABCA1genes become nonfunctional, Tangier disease develops. Given the ABCA1 transporter's essential role in HDL synthesis, researchers have theorized that mutations in one of the ABCA1 genes may alter HDL levels in the normal population. Anne Tybjrg-Hansen and colleagues at Copenhagen University Hospital now provide the evidence that indeed alterations in the ABCA1 gene affect HDL levels in the general population. The authors found that approximately 10% of individual with low HDL levels in the general population have a mutation or nucleotide modification in one of their ABCA1 genes. Furthermore, the researchers showed that the 4 out of 9 individuals with low HDL specifically carry 1 of the 2 mutations identified in families with Tangier disease. These data provide insight into the genetic changes that can contribute to variation of HDL in the general population and add to our current understanding of the variety of mechanisms that together contribute to increased or decreased susceptibility to cardiovascular disease.

An accompanying commentary places this study in the context of the function of the ABCA1 transporter and its impact on HDL production along with studies of the genetics and molecular mechanisms relating to Tangier disease.

TITLE: Genetic variation in ABC transporter A1 contr
'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
1-Nov-2004


Page: 1 2 3 4 5 6 7 8 9 10

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from ... and ProText™, making them the first Wharton’s jelly allografts to be assigned a Q ... company’s solutions are the first Wharton’s jelly allograft product to be recognized as a ...
(Date:7/22/2020)... ... July 21, 2020 , ... ... innovation in technology and compliance, announces a new solution to manage regulated workloads ... every layer of their technology stack complies with FDA and global regulations. USDM's ...
(Date:7/10/2020)... CHICAGO (PRWEB) , ... July 09, 2020 , ... Today ... Umami Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ... snacks. The Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... global consulting firm for the life sciences and food industries, is pleased to ... Director of Clinical Research – Business Development. , Charles is an accomplished and ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... ... 29, 2020 , ... The Interlocal Purchasing System (TIPS), a ... recently named BioFit Engineered Products an Awarded Vendor. Awarded Vendor status ... cafeteria tables, book trucks and carts at discounted pricing without the delay and ...
(Date:6/28/2020)... HILL, Conn. (PRWEB) , ... June 25, 2020 ... ... company formed to advance photodynamic therapy for treating cancer, today announced the company ... New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to ...
Breaking Biology Technology:
Cached News: